Contract facts
FederalIDIQ TASK ORDER is a federal award for Fda Office Of Acq Grant Svcs held by Tuvli LLC. Estimated value $9.6M ($20.8M obligated). Current period of performance ends Aug 14, 2027 (potential Aug 31, 2030). Place of performance: SILVER SPRING MD. Related solicitation FDARFTOP129971.
Recompete timing
PublicCurrent PoP ends Aug 14, 2027 (359 days remaining). Agencies typically plan 12–18 months ahead — at 11.8 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordTuvli LLC — $201.7M obligated across 187 awards (firm-wide, all agencies) · lead buyer Department of State (DOS).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75F40125F19006?
75F40125F19006 (IDIQ TASK ORDER) is a Fda Office Of Acq Grant Svcs award with a potential value of $9.6M, currently held by Tuvli LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75F40125F19006?
Fda Office Of Acq Grant Svcs awarded 75F40125F19006 to Tuvli LLC (potential $9.6M).
Who is the incumbent on 75F40125F19006?
Tuvli LLC is the incumbent with $201.7M across 187 related awards in SCOUT’s public footprint. The current period of performance ends Aug 14, 2027.
When does Tuvli LLC’s 75F40125F19006 come up for recompete?
SCOUT tracks a period-of-performance end of Aug 14, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
